Source comparison
CJC-1295 No DAC vs DAC: Timing Comparison
Half-life ~30 minutes ~6–8 days No DAC requires multiple daily doses; DAC allows once or twice weekly administration Dosing frequency 2–3 times daily Once or twice weekly No DAC demands stricter adherence but offers more control over pulse timing Pulse pattern
This comparison does not assign a generated winner or score.
- Half-life
- ~30 minutes
- ~6–8 days
- No DAC requires multiple daily doses; DAC allows once or twice weekly administration
- Dosing frequency
- 2–3 times daily
- Once or twice weekly
- No DAC demands stricter adherence but offers more control over pulse timing
- Pulse pattern
- Discrete amplification of endogenous pulses
- Sustained elevation with blunted peaks
- No DAC preserves physiological pulsatility; DAC creates non-physiological steady state
- Injection timing
- Must align with natural GH pulse windows
- Timing-independent due to sustained plasma levels
- No DAC is unforgiving—miss the window and you miss the amplification
- Receptor downregulation risk
- Lower due to intermittent exposure
- Higher due to continuous receptor occupancy
- No DAC's pulsatile pattern better maintains long-term receptor sensitivity
- Research applications
- Protocols requiring controlled pulse amplification
- Protocols where convenience outweighs physiological precision
- No DAC is superior for studies examining natural GH dynamics; DAC for sustained IGF-1 elevation